Stock Screener App

Frei -

Drug Manufacturers - Specialty & Generic

1.49

2.61% -0.04

Scynexis Inc (SCYX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt SCYX? Forum Prognose Aktiensplit

Scynexis Inc Aktie (SCYX) Neueste Nachrichten

SCYNEXIS (NASDAQ:SCYX) Shares Pass Below 200 Day Moving Average of $1.82 - MarketBeat

CRISPR Therapeutics: Prepare To Be Bored (NASDAQ:CRSP) - Seeking Alpha

Potential Price Increase for Synopsys, Inc. (SNPS) After Recent Insider Activity - Knox Daily

Scynexis CEO acquires $27,400 in company stock By Investing.com - Investing.com Canada

Syncona Advances Share Buyback, Bolsters Treasury Shares - TipRanks

Xero buys South African firm for $115m in 'departure' - New Zealand Herald

SCYNEXIS, Inc. (NASDAQ:SCYX) CEO Gonzalez David Angulo Buys 20,000 Shares - MarketBeat

Scynexis CEO acquires $27,400 in company stock - Investing.com

Synectics says trading is 'significantly ahead' of previous guidance - Proactive Investors USA

Better than expected profits forecast for security tech company - The Business Desk

Synopsys Inc. stock rises Friday, still underperforms market - MarketWatch

SCYNEXIS (NASDAQ:SCYX) Stock Crosses Below 200-Day Moving Average of $1.83 - MarketBeat

SCYNEXIS Advances Antifungal Treatments, Strengthens Financial Outlook - TipRanks

SCYNEXIS (NASDAQ:SCYX) Shares Cross Below 200-Day Moving Average of $1.84 - MarketBeat

Financial Fitness Check: Examining Scynexis Inc (SCYX)’s Key Ratios - The Dwinnex

SCYNEXIS to Participate in H. C. Wainwright 26th Annual Global Investment Conference - ForexTV.com

SCYNEXIS to Participate in H. C. Wainwright 26th Annual Global Investment Conference - StockTitan

SCYNEXIS (NASDAQ:SCYX) Downgraded by StockNews.com to Sell - Defense World

SCYNEXIS (NASDAQ:SCYX) Downgraded to "Sell" at StockNews.com - MarketBeat

SCYNEXIS Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

SCYX Stock Earnings: SCYNEXIS Misses EPS, Misses Revenue for Q2 2024 - InvestorPlace

Scynexis: Q2 Earnings Snapshot - San Antonio Express-News

Scynexis: Q2 Earnings Snapshot - San Francisco Chronicle

Scynexis: Q2 Earnings Snapshot - Press of Atlantic City

SCYNEXIS Reports Second Quarter 2024 Financial Results and Provides Corporate Update - wallstreet:online

Is SCYNEXIS (NASDAQ:SCYX) Using Too Much Debt? - Simply Wall St

Acadian Asset Management LLC Purchases 21,700 Shares of SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World

SCYNEXIS secures $10 million milestone from GSK - Investing.com India

SCYNEXIS secures $10 million milestone from GSK By Investing.com - Investing.com Canada

SCYNEXIS secures $10 million milestone from GSK - Investing.com

SCYNEXIS to Receive $10 Million Milestone Payment from GSK Triggered by Delivery of Completed FURI, CARES and NATURE Clinical Study Reports - StockTitan

3 Stocks Under $10 With the Potential for Massive Gains - InvestorPlace

Empowered Funds LLC Has $130,000 Position in SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World

3 Dirt-Cheap Drug Developers With Blockbuster Potential - InvestorPlace

SCYNEXIS Reports First Quarter 2021 Financial Results and Provides Corporate Update - Quantisnow

A Look Into Healthcare Sector Value Stocks - Quantisnow

Trade Alert: The CEO, President & Director Of SCYNEXIS, Inc. (NASDAQ:SCYX), Marco Taglietti, Has Just Spent US ... - Yahoo Movies UK

SCYNEXIS (NASDAQ:SCYX) shareholders are up 14% this past week, but still in the red over the last five years - Yahoo New Zealand News

SCYNEXIS (NASDAQ:SCYX) Stock Price Passes Below Fifty Day Moving Average of $2.01 - Defense World

SCYNEXIS (NASDAQ:SCYX) Share Price Crosses Below Fifty Day Moving Average of $2.01 - MarketBeat

Scynexis (SCYX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Lifestyle Singapore

SCYNEXIS Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders - Quantisnow

Ileal Sodium/Bile Acid Cotransporter Market 2030 | CJ HealthCare Corp, GlaxoSmithKline Plc, Scynexis Inc, Takeda ... - PrimePair

SCYNEXIS shareholders approve key proposals at annual meeting By Investing.com - Investing.com Australia

SCYNEXIS shareholders approve key proposals at annual meeting By Investing.com - Investing.com

Metric Analysis: Scynexis Inc (SCYX)'s Key Ratios in the Limelight – DWinneX - The Dwinnex

Lacklustre Performance Is Driving SCYNEXIS, Inc.'s (NASDAQ:SCYX) 32% Price Drop - Simply Wall St

Hidden Gems: 3 Under-$10 Stocks Poised for 500% Growth by 2025 - Yahoo Finance

Decheng Capital LLC Takes Position in SCYNEXIS, Inc. (NASDAQ:SCYX) - MarketBeat

Scynexis: 3Q Earnings Snapshot - Yahoo Movies UK

Ratio Revelations: Scynexis Inc (SCYX)'s Financial Metrics in the Spotlight – DWinneX - The Dwinnex

Investors in cash trouble should check out Scynexis Inc (SCYX) – Sete News - SETE News

SCYNEXIS, Inc. (NASDAQ:SCYX) Stock Holdings Increased by D.A. Davidson & CO. - Defense World

Scynexis (SCYX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Lifestyle UK

SCYX's 2023 Market Dance: Up 5.67% – Time to Invest? - The InvestChronicle

Stock Surge: Scynexis Inc (SCYX) Closes at 2.24, Marking a -11.46 Increase/Decrease – DWinneX - The Dwinnex

SCYNEXIS (NASDAQ:SCYX) Stock Passes Above 50 Day Moving Average of $1.66 - MarketBeat

Its Stock Has Paid Off Big Time For Scynexis Inc – Sete News - SETE News

SCYNEXIS (NASDAQ:SCYX) Shares Cross Above 50-Day Moving Average of $1.66 - Defense World

Scynexis Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - The InvestChronicle

$109.75

2.23%

$73.17

0.18%

$60.57

0.40%

$115.22

0.14%

$79.45

0.28%

$11.61

0.52%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | Open in MarketWatch | Open in EDGAR | Open in Reuters